Internal Documents Lead To Talcum Powder Ovarian Cancer Lawsuit Verdict Against Johnson and Johnson
A jury that handed down a large talcum powder ovarian cancer lawsuit verdict against Johnson & Johnson stated that internal J & J documents presented by the plaintiff's lawyers played a heavy role in their decision to levy more than $70 million in damages against the health care company.
Monday, February 22, 2016 - On of the leading pieces of evidence that led to a St. Louis jury handing down a debilitating talcum powder ovarian cancer lawsuit verdict to Johnson & Johnson (J&J) were internal documents from the health care company presented by attorneys representing the plaintiff in the case. The lawsuit, which was the first talcum powder case heard before the City of St. Louis Circuit Court, alleged that J&J was aware that there was scientific evidence that substantiate a causal link between talcum powder and an increased risk for contracting ovarian cancer and chose not to share that information with consumers. The jury that heard the case ruled heavily in favor of the plaintiff, ordering J&J to pay $10 million in compensatory damages and an additional $62 million to serve as a punishment for the defendant's actions surrounding the talcum powder allegations.
The talcum powder cancer lawsuit verdict was found in favor of the plaintiff in large part because of internal documents presented as evidence against J&J. The jury found that these documents proved that J&J was aware of the severity concerning the connections being made in the scientific community between their talcum powder products and an increased risk for women using the products regularly to develop ovarian cancer.
The jury foreman went as far to claim that the J&J internal documents were one of the main reasons that they found in favor of the plaintiff and at such a steep cost for the defendant. Their eventual talcum powder lawsuit verdict hinged on the fact that the documents represented J&J as intentionally concealing evidence of a link between talcum powder and ovarian cancer from consumers, and that no effort was made to even affix a warning label to their talcum powder products.
The verdict reached by the jury is a big win for the roughly 1,200 talcum powder ovarian cancer lawsuits currently pending nationwide. This case was seen as a bellwether for future talcum powder claims that contained similar claims concerning the product's link to ovarian cancer. The verdict increased the chance of a large, lump sum settlement from J&J in the future to settle claims given the huge damage awarded by the jury, and more talcum powder lawsuits are expected to be filed around the country following this trial. The talcum powder ovarian cancer lawsuit verdict from the City of St. Louis Circuit Court jury is great news for potential plaintiffs that are looking to file suit against J&J over their talcum powder products.
No-Cost, No-Obligation Baby Powder Cancer Lawsuit Case Review for Women and Families of Women Who Were Diagnosed with Ovarian Cancer and Have a History of Using Talcum Powder
The Onder Law Firm
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit Talcum Powder Cancer Lawsuit Center or call 1-877-ONDER-LAW.